AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 298 filers reported holding AVANOS MED INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $69,000 | -24.2% | 2,507 | -7.3% | 0.00% | -100.0% |
| Q1 2022 | $91,000 | +19.7% | 2,704 | +23.9% | 0.00% | 0.0% |
| Q4 2021 | $76,000 | +28.8% | 2,183 | +15.6% | 0.00% | – |
| Q3 2021 | $59,000 | -21.3% | 1,888 | -8.5% | 0.00% | -100.0% |
| Q2 2021 | $75,000 | -26.5% | 2,064 | -11.5% | 0.00% | 0.0% |
| Q1 2021 | $102,000 | -60.9% | 2,332 | -59.0% | 0.00% | -66.7% |
| Q4 2020 | $261,000 | +39.6% | 5,682 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $187,000 | +3.3% | 5,652 | -6.3% | 0.00% | 0.0% |
| Q2 2020 | $181,000 | -5.7% | 6,034 | +17.6% | 0.00% | -57.1% |
| Q3 2019 | $192,000 | -15.0% | 5,131 | -1.0% | 0.01% | -12.5% |
| Q2 2019 | $226,000 | +310.9% | 5,182 | +305.5% | 0.01% | +300.0% |
| Q1 2019 | $55,000 | 0.0% | 1,278 | +4.2% | 0.00% | -33.3% |
| Q4 2018 | $55,000 | -46.6% | 1,226 | -18.5% | 0.00% | -40.0% |
| Q3 2018 | $103,000 | +267.9% | 1,505 | +211.0% | 0.01% | +150.0% |
| Q2 2018 | $28,000 | – | 484 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |